HOCOMA

Company Snapshot

Founded: 1996
Entity Type: Private
Region: Switzerland
Headquarter: Volketswil, Switzerland
Key Geographics: North America, Latin America, Europe, Asia, Australia, Middle East and Africa
Corporate Address: Industriestrasse 4 8604 Volketswil Switzerland Tel. +41-43-444-22-00 www.hocoma.com

Company Overview

Hocoma AG, founded in 1996, is a developer, manufacturer, and marketer of robotic and sensor-based devices for functional movement therapy. The company’s primary goal is the improvement of the treatment of neurological patients. The company’s products serve patients looking for the following medicines: upper extremities, lower extremities, early rehabilitation, and back treatment. The solutions provided by the company are intensive locomotion therapy; functional therapy of the upper extremities; patient mobilization in early rehabilitation programs; functional over-ground gait therapy with dynamic body weight support; and functional movement therapy for lower back pain treatment.

Hocoma’s product portfolios are categorized into Lokomat-Robotic Gait Therapy; LokomatPro with FreeD; Andago - new perspectives in functional gait therapy; Armeo Therapy Concept - arm and hand therapy; Erigo - innovation for early rehabilitation programs; and Valedo therapy concept - for a healthy back.

Lokomat robotic gait therapy is used to assist in the walking movements of gait-impaired patients and mobility in individuals following stroke, spinal cord injury, cerebral palsy, and other neurological diseases and injuries. LokomatPro with FreeD is used to improve Lokomat robotic gait therapy by enabling lateral translation and transverse rotation of the pelvis. Andago is used for upright, hands-free walking without spatial limitations of the body weight support. Armeo is used to motivate the patients from within and thus rely less on the therapist. Erigo is used to improve muscle strength in lower extremities and cerebral blood flow. Valedo is used to provide a continuous solution for spine assessment to therapy.

HOCOMA In Reports

Surgical Navigation Systems: Technologies and Global Markets

BCC Research Market Analysis Report says market for surgical navigation systems is estimated to increase from $1.2 bln in 2022 to reach over $1.8 bln by 2027 at CAGR of 9.0%.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

BCC Research Market Report for Chronic Disease Management. Global Chronic Disease Management market trends, with CAGRs through 2026.

Medical Robotics and Computer-assisted Surgery: The Global Market

BCC Research Market Report says surgical robotics and computer-assisted surgery should grow from $6.1 billion in 2020 to $11.6 billion by 2025 with a CAGR of 13.5%.

Company's Business Segments

  • Robotics & Sensor-based Devices : The company provides robotic and sensor-based devices for functional movement therapy, advanced technologies and solutions for movement rehabilitation, including devices for gait training (Lokomat), upper extremity therapy (Armeo), and early rehabilitation (Erigo).

Applications/End User Industries

  • Patients
  • Therapists
AI Sentiment